.png){kind=icon}
S
Shuai Wang
H指数:23
被引数:1,742
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Novel hydrazone-linked pyridin-1-ium salts as multi-targeted agents for Alzheimer's disease: design, synthesis, in vitro and in silico studies
新型腙连接的吡啶-1-鎓盐作为阿尔茨海默病多靶点药物：设计、合成、体外及计算机模拟研究
AI-Optimized 3D-Printed Dual-Layer Implant: Resolving Chemo-Immunotherapy Sequential Administration Dilemma for Colorectal Cancer Peritoneal Metastasis
AI优化的3d打印双层植入物: 解决结直肠癌腹膜转移的化学免疫疗法序贯给药困境
Advanced Materials
IF26.8
Mesoporous Catalytic-Adsorptive Nanoregulator Orchestrates Biofilm eDNA/LPS Disassembly and TLR9/TLR4 Immune Reprogramming to Resolve Diabetic Foot Infections
介孔催化-吸附纳米调节器调控生物膜外源DNA/脂多糖解聚及TLR9/TLR4免疫重编程以解决糖尿病足感染
Advanced Science
IF14.1
Discovery of novel and potent non-nucleoside reverse transcriptase inhibitors through structure-based drug design for HIV treatment
通过基于结构的药物设计发现新型且高效的HIV治疗非核苷类逆转录酶抑制剂
Halogenation-Driven Discovery of Halomethylene-Biphenyl-Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Safety and PK Profiles
卤代作用驱动的卤代亚甲基-联苯-二芳基嘧啶类化合物作为具有改善安全性和药代动力学特性的强效HIV-1非核苷类逆转录酶抑制剂的开发
Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors
生物等排体驱动的口服活性、安全且广谱的二苯基-DAPY衍生物的设计，作为高活性HIV-1非核苷类反转录酶抑制剂
Cross-subclass metallo-β-lactamase inhibitors: From structural and catalytic commonalities guiding design
跨亚类金属β-内酰胺酶抑制剂的共性与设计指导：结构及催化相似性
